Abstract
The invention relates to a bioactive fraction of Petivería alliacea having an antitumour activity, and to the use of same for producing medicaments for treating cancer. The invention also relates to a pharmaceutical combination for treating cancer, comprising the bioactive fraction of Petiveria alliacea and at least one immunostimulant that can produce the phenotypic and/or functional maturation of the dendritic cells. The invention further relates to a method for treating cancer, comprising the sequential administration of the bioactive fraction of Petiveria alliacea or the composition containing same and an immunostimulating agent.
| Original language | English |
|---|---|
| Publication/registration number | WO2011039629 |
| International Classification | A61P 35/ 00 A I |
| Grant date | 02/10/09 |
| Filing date | 22/09/10 |
| State | Published - 07 Apr 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'BIOACTIVE FRACTION OF PETIVERIA ALLIACEA, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND COMBINATION WITH IMMUNOSTIMULANTS FOR TREATING CANCER'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver